Sartorius Stedim Biotech

First-Half Financial Report

January to June 2020

At a glance

Sales revenue

€ 869.1m

currency adjusted: + 22.0 %

Underlying EBITDA margin

30.2 %

+ 1.3 percentage points

Underlying EPS

€ 1.82

+ 27.7 %

1
2
3

Service

Download tables (Excel)

Financial Calendar

Financial Calendar